Raf inhibitor compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9187474
APP PUB NO 20150105367A1
SERIAL NO

14383803

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention provides compounds of Formula (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising a compound of Formula (I); and use of a compound of Formula (I) for treating specified cancers.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DECIPHERA PHARMACEUTICALS LLCWALTHAM MA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Caldwell, Timothy Malcolm Fishers, US 7 282
Flynn, Daniel L Lawrence, US 173 4670
Henry, James R Indianapolis, US 13 185
Hipskind, Philip A Indianapolis, US 17 249
Kaufman, Michael D Lawrence, US 71 1964
Lu, Wei-Ping Lawrence, US 7 131
Patt, William C Lawrence, US 23 609
Peng, Sheng-Bin Indianapolis, US 13 119
Smith, Bryan Lawrence, US 51 2239
Vogeti, Lakshminarayana Lawrence, US 27 425
Wise, Scott Lawrence, US 3 122

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 17, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00